Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 2, 2008

Fujirebio Diagnostics Takes Over American Biological Technologies

  • Fujirebio Diagnostics acquired American Biological Technologies marking its entry into the controls and calibrators manufacturing business. The company says the merger will strengthen its position in the in vitro diagnostics industry.

    American Biological Technologies has been one of Fujirebio Diagnostics' main suppliers for several years, providing controls and calibrators to a shared customer base. The acquisition will thus streamline delivery of material used in products sold to laboratory customers.

    American Biological Technologies’ products are designed to work with a wide variety of diagnostic equipment and in virtually any diagnostic laboratory, according to the firms. While Fujirebio Diagnostics specializes in oncology diagnostics, the versatility of the acquired company’s products will enable Fujirebio Diagnostics to tap into the management of other diseases such as diabetes, says Monte Wiltse, vp of marketing and sales.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »